On August 24, Shape Therapeutics (ShapeTX) announced a cooperation agreement with Roche, under which the two parties will joint
On August 24, Novartis announced that the CD19 CAR-T therapy Kymriah's second-line treatment of aggressive B-cell non-Hodgkin l
Recently, Ganli Pharmaceutical Co., Ltd. (hereinafter referred to as "Ganli Pharmaceutical", stock code: 603087.SH) insulin lispro injection o
On August 19, Jiangsu Hengrui Pharmaceutical Co., Ltd. (Hengrui Pharmaceutical, 600276) released the first half of 2021 p
Recently, Novartis ranibizumab was approved for new indications, including retinopathy of prematurity (ROP) and diabetic retino
In recent days, centralized procurement has been frequent. As soon as the special centralized procurement of Chinese pate
Recently, Science Bulletin (Science Bulletin, Impact Factor: 11.780), an international authoritative natural science comprehens
Recently, the National Medical Insurance Administration, in reply to the recommendation No. 4126 of the Fourth Session of the T
The global COVID-19 pandemic has returned, and the pandemic alert has once again made all countries suffer. Even China, which h
It has been more than a month since the multinational pharmaceutical companies began to publish their semi-annual reports. With
Recently, Yaozhi data shows that the listing application of WuXi's Noreki Orencel injection (relma-cel) has entered the "pendin
On August 9, the National Medical Insurance Administration issued the "Response of the National Medical Insurance Administratio
Recently, Sanofi announced that it has reached a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutic dru
On August 3, the three major A-share indexes opened lower across the board in the morning trading, and the fluctuations continu
According to the consistency evaluation analysis system of Yaozhi Data Enterprise Edition, 80 new consistency evaluation acceptance numbers were added in July 2021;
On July 30, the listing application for the CAR-T product, relma-cel, of WuXi Giant Nuo targeting CD19, has been completed on-s
Today (August 2nd), Fortune PlusAPP released the latest Fortune Global 500 list simultaneously with the world. Affected by the new crown epidemic, the operating inc
Since July, according to incomplete statistics from Yaozhi.com, as of July 30, 10 companies including Johnson & Johnson, Pf
On July 29, local time, Gilead Sciences (GILD.US) released its financial report for the second quarter ending June 30, 2021. The financial report shows that Gilead
According to the latest announcement from the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China, two new drugs are planned t
The approval of new drugs is the holy grail for large and small pharmaceutical companies, and the track record of bringing new
In recent years, global bispecific antibodies have been growing rapidly in the preclinical and clinical stages. Up to now, 4 du
Over the weekend, Cansino announced the performance forecast for the first half of 2021. During the period, it is expected to realize operating income of 2-2 billio
Yaozhi data shows that in this period (July 9 to July 16), 26 new drugs were approved clinically (32 acceptance numbers); another 41 varieties (52 acceptance number
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
